$2.17
-0.06-2.69%
Last update: Oct 30, 5:25 PM
Atossa Therapeutics Inc (ATOS) Stock Price, Quote, News & History
ATOSNASDAQ
US stocks rise with Nasdaq up 150 points. Dow up 0.54%, Nasdaq up 0.63%, S&P 500 up 0.26%. Industrials and Enliven Therapeutics lead gains. Dana Inc and...
You can purchase shares of Atossa Therapeutics (NASDAQ:ATOS) through any online brokerage.
Other companies in Atossa Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Atossa Therapeutics has a consensus price target of $20.50.
The stock price for Atossa Therapeutics (NASDAQ: ATOS) is $2.2793 last updated October 30, 2026 at 5:25 PM EDT.
There are no upcoming dividends for Atossa Therapeutics.
Atossa Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Atossa Therapeutics.
Atossa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is...
